SZENF yields 285.71% · JNJ yields 2.13%● Live data
📍 SZENF pulled ahead of the other in Year 1
Combined, SZENF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SZENF + JNJ for your $10,000?
Seazen Group Limited, together with its subsidiaries, engages in the investment, development, and sale of properties in the People's Republic of China. It primarily develops and sells residential properties and mixed-use complexes, as well as provides commercial property management and other services. As of December 31, 2021, the company had total land bank of approximately 138 million square meters. It also provides asset operation and management, information technology, and children entertainment, and cinema management services. In addition, the company offers securities and future brokerage, and money lending services, as well as dealing and advising services of securities. Further, it provides architecture designing services; and designs, manufactures, and sells auto parts. The company was formerly known as Future Land Development Holdings Limited and changed its name to Seazen Group Limited in November 2019. The company was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Seazen Group Limited is a subsidiary of Wealth Zone Hong Kong Investments Limited.
Full SZENF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.